Neogen Co. (NASDAQ:NEOG) CFO Steven J. Quinlan sold 2,000 shares of the business’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $60.15, for a total transaction of $120,300.00. Following the completion of the transaction, the chief financial officer now owns 15,470 shares of the company’s stock, valued at $930,520.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of Neogen Co. (NEOG) traded up $0.62 during midday trading on Friday, reaching $60.11. 131,326 shares of the company traded hands, compared to its average volume of 175,763. The stock has a market cap of $3,065.08, a price-to-earnings ratio of 59.81, a PEG ratio of 3.69 and a beta of 1.46. Neogen Co. has a 12 month low of $44.63 and a 12 month high of $64.42.
Neogen (NASDAQ:NEOG) last issued its quarterly earnings results on Wednesday, January 3rd. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.26 by $0.07. The company had revenue of $101.80 million during the quarter, compared to analyst estimates of $102.46 million. Neogen had a net margin of 13.47% and a return on equity of 10.72%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.29 EPS. sell-side analysts anticipate that Neogen Co. will post 1.08 EPS for the current fiscal year.
Several equities analysts recently issued reports on NEOG shares. Zacks Investment Research cut shares of Neogen from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Roth Capital started coverage on shares of Neogen in a research note on Tuesday, December 5th. They issued a “neutral” rating and a $61.50 target price for the company. Craig Hallum boosted their target price on shares of Neogen from $46.50 to $60.00 and gave the company a “hold” rating in a research note on Thursday, December 7th. Stephens reiterated a “hold” rating and issued a $62.00 target price on shares of Neogen in a research note on Wednesday, January 10th. Finally, BidaskClub lowered shares of Neogen from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $63.25.
Several institutional investors have recently added to or reduced their stakes in NEOG. Wasatch Advisors Inc. grew its holdings in shares of Neogen by 619.3% during the fourth quarter. Wasatch Advisors Inc. now owns 1,023,040 shares of the company’s stock worth $84,104,000 after buying an additional 880,819 shares in the last quarter. Conestoga Capital Advisors LLC boosted its position in shares of Neogen by 20.2% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 958,784 shares of the company’s stock valued at $74,267,000 after acquiring an additional 161,170 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Neogen by 33.7% during the 4th quarter. Geode Capital Management LLC now owns 451,973 shares of the company’s stock valued at $27,867,000 after acquiring an additional 113,850 shares during the last quarter. Citadel Advisors LLC boosted its position in shares of Neogen by 338.6% during the 3rd quarter. Citadel Advisors LLC now owns 143,553 shares of the company’s stock valued at $11,120,000 after acquiring an additional 110,821 shares during the last quarter. Finally, McCollum Christoferson Group LLC acquired a new position in shares of Neogen during the 4th quarter valued at about $8,225,000. 66.13% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/24/neogen-co-neog-cfo-steven-j-quinlan-sells-2000-shares-of-stock.html.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.